127 related articles for article (PubMed ID: 16414264)
1. Efficient approach to acyloxymethyl esters of nalidixic acid and in vitro evaluation as intra-ocular prodrugs.
Azéma J; Guidetti B; Malet-Martino M; Martino R; Roques C
Bioorg Med Chem; 2006 Apr; 14(8):2569-80. PubMed ID: 16414264
[TBL] [Abstract][Full Text] [Related]
2. Towards calixarene-based prodrugs: Drug release and antibacterial behaviour of a water-soluble nalidixic acid/calix[4]arene ester adduct.
Dibama HM; Clarot I; Fontanay S; Salem AB; Mourer M; Finance C; Duval RE; Regnouf-de-Vains JB
Bioorg Med Chem Lett; 2009 May; 19(10):2679-82. PubMed ID: 19395263
[TBL] [Abstract][Full Text] [Related]
3. A prodrug approach toward the development of water soluble fluoroquinolones and structure--activity relationships of quinoline-3-carboxylic acids.
Baker WR; Cai S; Dimitroff M; Fang L; Huh KK; Ryckman DR; Shang X; Shawar RM; Therrien JH
J Med Chem; 2004 Sep; 47(19):4693-709. PubMed ID: 15341485
[TBL] [Abstract][Full Text] [Related]
4. Nalidixic acid prodrugs: amides from amino acid esters and nalidixic acid.
Kohli DV; Uppadhyay RK; Saraf SK; Vishwakarma KK
Pharmazie; 1992 Jan; 47(1):57-9. PubMed ID: 1608986
[No Abstract] [Full Text] [Related]
5. Synthesis of zidovudine prodrugs with broad-spectrum chemotherapeutic properties for the effective treatment of HIV/AIDS.
Sriram D; Srichakravarthy N; Bal TR; Yogeeswari P
Biomed Pharmacother; 2005 Sep; 59(8):452-5. PubMed ID: 16154314
[TBL] [Abstract][Full Text] [Related]
6. In vitro synergism of nalidixic acid with other broad spectrum antibiotics.
Piccolomini R; Cellini L; Allocati N; Ravagnan G
Chemioterapia; 1984 Apr; 3(2):103-7. PubMed ID: 6532536
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro investigations of nalidixic acid amides of amino acid esters as prodrugs.
Aboul-Fadl T; Fouad EA
Pharmazie; 1996 Jan; 51(1):30-3. PubMed ID: 8999431
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, primary photophysical and antibacterial properties of naphthyl ester cinoxacin and nalidixic acid derivatives.
Vargas F; Zoltan T; Rivas C; Ramirez A; Cordero T; Díaz Y; Izzo C; Cárdenas YM; López V; Gómez L; Ortega J; Fuentes A
J Photochem Photobiol B; 2008 Aug; 92(2):83-90. PubMed ID: 18562206
[TBL] [Abstract][Full Text] [Related]
9. Increasing resistance to nalidixic acid in Shigella subgroups in a comparative study between 2001-2003 and 2004-2006.
Mamishi S; Mashoori N; Mahboobi N; Pour Akbari B
Singapore Med J; 2009 Aug; 50(8):791-3. PubMed ID: 19710978
[TBL] [Abstract][Full Text] [Related]
10. Nalidixic acid prodrugs: amides from amino acid ester and nalidixic acid.
Taori A; Nema R; Kohli DV; Uppadhyay RK
Arch Pharm Res; 1991 Mar; 14(1):48-51. PubMed ID: 10319121
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of stavudine amino acid ester prodrugs with broad-spectrum chemotherapeutic properties for the effective treatment of HIV/AIDS.
Sriram D; Yogeeswari P; Srichakravarthy N; Bal TR
Bioorg Med Chem Lett; 2004 Mar; 14(5):1085-7. PubMed ID: 14980640
[TBL] [Abstract][Full Text] [Related]
12. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection.
Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY
Eur J Pharm Sci; 2009 Sep; 38(2):138-46. PubMed ID: 19591929
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of degradation and oil solubility of ester prodrugs of a model dipeptide (Gly-Phe).
Larsen SW; Ankersen M; Larsen C
Eur J Pharm Sci; 2004 Aug; 22(5):399-408. PubMed ID: 15265509
[TBL] [Abstract][Full Text] [Related]
14. [On the problem of in vitro sensitivity of some Salmonellae to antimicrobial substances (author's transl)].
Jedlicková Z; Matĕjovská D
Cesk Epidemiol Mikrobiol Imunol; 1975 Mar; 24(2):90-6. PubMed ID: 124226
[No Abstract] [Full Text] [Related]
15. [In vivo comparative evaluation of the activity of antibacterial drugs on aerobic fecal flora].
Bertazzoni E; Ceroni A; Benoni G; Berti T
Clin Ter; 1974 Apr; 69(2):99-112. PubMed ID: 4275860
[No Abstract] [Full Text] [Related]
16. [Microbial sensitivity to various antibacterials, including nalidixic acid. 2,458 Gram negative bacilli strains of diverse origins, especially urinary].
Chamfeuil R; Curcier H
Therapeutique; 1969 Oct; 45(8):757-62. PubMed ID: 5386084
[No Abstract] [Full Text] [Related]
17. Aminocarbonyloxymethyl ester prodrugs of flufenamic acid and diclofenac: suppressing the rearrangement pathway in aqueous media.
Ribeiro L; Silva N; Iley J; Rautio J; Järvinen T; Mota-Filipe H; Moreira R; Mendes E
Arch Pharm (Weinheim); 2007 Jan; 340(1):32-40. PubMed ID: 17206608
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a novel polymeric prodrug of an antibacterial agent synthesized by mechanochemical solid-state polymerization.
Yamauchi Y; Doi N; Kondo SI; Sasai Y; Kuzuya M
Drug Dev Res; 2020 Nov; 81(7):867-874. PubMed ID: 32501557
[TBL] [Abstract][Full Text] [Related]
19. Water-soluble phosphate prodrugs of pleuromutilin analogues with potent in vivo antibacterial activity against Gram-positive pathogens.
Fu L; Jiang Z; Cai Z; Liu X; He H; Yang Y
Bioorg Med Chem Lett; 2009 Sep; 19(18):5407-10. PubMed ID: 19682897
[TBL] [Abstract][Full Text] [Related]
20. Effect of nalidixic acid on the morphology and protein expression of Pseudomonas aeruginosa.
Al Bahry S; Sivakumar N; Al-Khambashi M
Asian Pac J Trop Med; 2012 Apr; 5(4):265-9. PubMed ID: 22449516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
